Karen Kaul to Immunomodulation
This is a "connection" page, showing publications Karen Kaul has written about Immunomodulation.
Connection Strength
0.042
-
An Oncolytic Adenovirus Targeting Transforming Growth Factor ß Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 Therapy. Hum Gene Ther. 2019 09; 30(9):1117-1132.
Score: 0.042